Search

Your search keyword '"Kukreti, Vishal"' showing total 1,010 results

Search Constraints

Start Over You searched for: Author "Kukreti, Vishal" Remove constraint Author: "Kukreti, Vishal"
1,010 results on '"Kukreti, Vishal"'

Search Results

8. Canadian cancer trials group LY.17: A randomized phase II study evaluating novel salvage therapy pre‐autologous stem cell transplant in relapsed/refractory diffuse large B‐cell lymphoma—outcome of rituximab‐dose‐intensive cyclophosphamide, etoposide, cisplatin (R‐DICEP) versus R‐GDP

12. A pharmacokinetics and safety phase 1/1b study of oral ixazomib in patients with multiple myeloma and severe renal impairment or end-stage renal disease requiring haemodialysis.

16. Brentuximab vedotin plus bendamustine in relapsed or refractory Hodgkin's lymphoma: an international, multicentre, single-arm, phase 1–2 trial

17. The evaluation of monoclonal gammopathy of renal significance: a consensus report of the International Kidney and Monoclonal Gammopathy Research Group

22. Carfilzomib significantly improves the progression-free survival of high-risk patients in multiple myeloma

23. Phase 2 study of panobinostat with or without rituximab in relapsed diffuse large B-cell lymphoma

26. Ambulatory Toxicity Management (AToM) Pilot: results of a pilot study of a pro-active, telephone-based intervention to improve toxicity management during chemotherapy for breast cancer

30. Five hematologic tests and treatments to question

31. The I-Can Manage web-based cancer self-management program targeting treatment toxicities and health behaviours: Human centred co-design approach and cognitive-think aloud usability testing (Preprint)

32. Human centered co-design and usability testing of a web-based cancer self-management education program (I-Can Manage) targeting treatment toxicities and health behaviours (Preprint)

33. Chromosome 1q Abnormalities Are Not an Independent Predictor of Survival in Multiple Myeloma

35. Frailty in Patients Undergoing Chimeric Antigen Receptor T-Cell (CAR T) Therapy at Princess Margaret Cancer Centre: A Prospective Pilot Study

36. Correlation Amongst Scoring of Various Frailty Tools in Myeloma Patients Undergoing Autologous Stem Cell Transplantation

37. Crebbp Mutations Are Associated with Shorter Time to Progression in Limited-Stage Follicular Lymphoma Treated with Radiation

40. From Choosing Wisely to Implementing Wisely in Cancer Care: A Scoping Review

42. Clinical significance of clonal hematopoiesis in the setting of autologous stem cell transplantation for lymphoma

47. A phase 2 study of single-agent carfilzomib (PX-171-003-A1) in patients with relapsed and refractory multiple myeloma

48. An open-label, single-arm, phase 2 (PX-171-004) study of single-agent carfilzomib in bortezomib-naive patients with relapsed and/or refractory multiple myeloma

50. Publisher Correction: The evaluation of monoclonal gammopathy of renal significance: a consensus report of the International Kidney and Monoclonal Gammopathy Research Group

Catalog

Books, media, physical & digital resources